Search Results
Test Catalog
LEIS - Overview: Leishmaniasis (Visceral) Antibody, Serum
Aiding in the diagnosis of active visceral leishmaniasis This test should not be used as the sole criteria for diagnosis.
MEX - Overview: Mexiletine, Serum
Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity
LEVE - Overview: Levetiracetam, Serum
Monitoring serum concentration of levetiracetam, particularly in patients with kidney disease Assessing compliance with levetiracetam therapy Assessing potential toxicity of levetiracetam
ALBLI - Overview: Limited Bleeding Diathesis Profile Interpretation
Interpretation of testing performed as part of a profile to detect of the more common potential causes of abnormal bleeding (eg, factor deficiencies/hemophilia, von Willebrand disease, factor-specific inhibitors) and a simple screen to...
LID - Overview: Lidocaine, Serum
Assessing optimal lidocaine dosing during the acute management of ventricular arrhythmias following myocardial infarction or during cardiac manipulation such as surgery Assessing potential lidocaine toxicity
KIPM - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Manual
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases, using a manual method
LD - Overview: Lactate Dehydrogenase (LDH), Serum
Investigation of a variety of diseases involving the heart, liver, muscle, kidney, lung, and blood Monitoring changes in tumor burden after chemotherapy; lactate dehydrogenase elevations in patients with cancer are too erratic to be of use...
LACO - Overview: Lacosamide, Serum
Monitoring serum concentrations of lacosamide to ensure compliance and appropriate dosing in specific clinical conditions (ie, severe kidney impairment, mild-to-moderate hepatic impairment, and kidney failure)
MAGES - Overview: Myelin-Associated Glycoprotein Autoantibodies, IgM, Serum
Evaluating peripheral neuropathy Evaluating paraproteinemic neuropathy
FFMSS - Overview: Maternal Serum Screening, Integrated, Specimen #1, PAPP-A, NT
First-trimester screening test for trisomy 21 (Down syndrome), trisomy 18, and open neural tube defects
MTXSG - Overview: Methotrexate Post Glucarpidase, Serum
Monitoring methotrexate concentrations post-glucarpidase therapy Documenting failure to respond that may be due to noncompliance Guiding dosage adjustments in patients with kidney failure
SORBU - Overview: Sorbitol and Mannitol, Quantitative, Random, Urine
Monitoring effectiveness of treatment in patients with phosphomannomutase 2 deficiency (PMM2-CDG) Establishing a baseline level prior to initiating treatment for PMM2-CDG This test is not useful for diagnosing congenital disorders of...
TPIC - Overview: Triosephosphate Isomerase Enzyme Activity, Blood
Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency
URCU - Overview: Uric Acid, 24 Hour, Urine
Assessment and management of patients with kidney stones, particularly uric acid stones
RNAUR - Overview: Sodium, Random, Urine
Assessing acid-base balance, water balance, water intoxication, and dehydration
TRMP - Overview: Trimipramine, Serum
Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance
TLB - Overview: Thallium, Blood
Detecting toxic exposure in whole blood specimens
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
TAKRO - Overview: Tacrolimus, Blood
Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
TBGI - Overview: Thyroxine-Binding Globulin (TBG), Serum
Cases in which total thyroid hormone levels do not correlate with the thyrometabolic status, most commonly with pregnancy or the use of contraceptive steroids
T46CS - Overview: Tripartite Motif-Containing Protein 46 (TRIM46) IgG, Cell Binding Assay, Serum
Detecting tripartite motif-containing protein 46 (TRIM46)-IgG by cell-binding assay using serum specimens Evaluation of an autoimmune/paraneoplastic neurological syndrome among patients presenting with cerebellar ataxia, encephalitis, or...
TOPI - Overview: Topiramate, Serum
Monitoring serum concentrations of topiramate Assessing compliance Assessing potential toxicity
TRIGC - Overview: Triglycerides, CDC, Serum
Measurement of triglycerides as part of lipoprotein profiling
URAU - Overview: Urea, 24 Hour, Urine
Assessment of protein intake and/or nitrogen balance
SDLDL - Overview: Small Dense Low Density Lipoprotein Cholesterol, Serum
Aiding in risk management of lipoprotein disorders associated with cardiovascular disease when used in conjunction with other lipid measurements and clinical evaluation
Assessing acid-base balance, water balance, water intoxication, and dehydration
THEO - Overview: Theophylline, Serum
Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity
MSTC - Overview: Strict Criteria Sperm Morphology for Infertility Diagnosis and Treatment, Semen
Diagnosing male infertility Selecting the most cost-effective therapy for treating male-factor infertility Quantifying the number of germinal and white blood cells per mL of semen
TOBRA - Overview: Tobramycin, Random, Serum
Monitoring adequacy of serum concentration during tobramycin therapy This unit code is used whenever a specimen is submitted or collected without collection timing information. The phlebotomist should use this unit code if she or he does...
TRYPU - Overview: Tryptophan, Random, Urine
Aiding in the screening and monitoring of Hartnup disease
SPNC - Overview: Streptococcus pneumoniae Antigen, Spinal Fluid
Rapid diagnosis of pneumococcal meningitis
SP7TS - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-7 IgG in serum specimens Reporting an end titer result from serum specimens
THSD7 - Overview: Thrombospondin Type-1 Domain-Containing 7A Antibodies, Serum
Distinguishing primary from secondary membranous nephropathy cases with antibodies against THSD7A
CHAGI - Overview: Trypanosoma cruzi, Technical Interpretation
Diagnosis of chronic Trypanosoma cruzi infection (Chagas disease)
VORI - Overview: Voriconazole, Serum
Monitoring trough levels of voriconazole suggested for: -Individuals with reduced liver function -Individuals with cytochrome P450 (CYP) 2C19 alterations associated with poor metabolic function -Patients taking other medications that affect...
VDSFT - Overview: VDRL Titer, Spinal Fluid
Aid in the diagnosis of neuroinvasive syphilis as part of a profile
VANRA - Overview: Vancomycin, Random, Serum
Monitoring adequacy of drug concentration during vancomycin therapy whenever a specimen is submitted or collected without collection timing information
VANTA - Overview: Vancomycin, Trough, Serum
Preferred test for monitoring vancomycin therapy Monitoring trough concentrations drawn at steady-state in selected patients receiving vancomycin therapy
VANPA - Overview: Vancomycin, Peak, Serum
Monitoring peak levels in selected patients receiving vancomycin therapy
VALPF - Overview: Valproic Acid, Free, Serum
Monitoring free valproic acid in therapy Assessing compliance Evaluating potential toxicity
21OH - Overview: 21-Hydroxylase Antibodies, Serum
Investigating adrenal insufficiency Aiding in the detection of those at risk of developing autoimmune adrenal failure in the future
FLUC - Overview: 5-Flucytosine, Serum
Monitoring serum concentration during therapy Evaluating potential toxicity May aid in evaluating patient compliance
PENTS - Overview: Pentobarbital, Serum
Monitoring of pentobarbital therapy treatment
CRUO - Overview: Chromium Occupational Exposure, Random, Urine
Screening for occupational exposure
VITB2 - Overview: Riboflavin (Vitamin B2), Plasma
Evaluation of individuals who present the signs of ariboflavinosis
VLTU - Overview: Volatile Screen, Random, Urine
Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation
ALKLC - Overview: Anaplastic Lymphoma Kinase for Lung Cancer, Immunohistochemistry
Identification of anaplastic lymphoma kinase (ALK) expression Prediction of tumor response to targeted therapy of non-small cell lung carcinomas.
F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time
COKEU - Overview: Cocaine and Metabolite Confirmation, Random, Urine
Detecting and confirming drug abuse involving cocaine This test is not intended for employment-related testing.
BARBU - Overview: Barbiturates Confirmation, Random, Urine
Detecting drug abuse involving barbiturates such as amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital
Site Search
Problem-Solving Thinking: An Overview of DMAIC, A3, and PDSA - Insights
PACE/State of FL - What problem-solving thinking is, as well as an overview of what DMAIC, A3, and PDSA problem-solving approaches are to support your quality and continuous improvement journey....
MayoLINK Overview Video - Mayo Clinic Laboratories
MayoLINK Overview Video - Mayo Clinic Laboratories Share Print
FISH probe & panel project: An overview - Insights
In this month's "Hot Topic," Jess Peterson, M.D., discusses changes to Mayo Clinic Laboratories’ hematology FISH menu to increase awareness, provide reasoning, and highlight some of the great things that are coming.
Lab Billing, Coding, and Compliance: A 2025 Overview - Insights
PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.
MGLE - Overview: Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...